For IP professionals
This is the portal for professionals working in the field of intellectual property. Here you'll find direct access to all necessary resources.
Quick links
- Trade Mark Database
- Register changes for trade marks
- Swissreg
- Madrid Monitor
- TMview
- E-trademark
- International trade mark registration
- Trade Mark Guidelines (German, French, Italian)
- Classification tool for trade marks
- Trade mark examination support tool
- Trade marks: Costs and fees
- Trade marks: WIPO fee calculator
- Cancellation procedure for trade marks on the grounds of non-use
- Protected public signs: Abbreviations
- Protected public signs: Other signs (emblems)
- Directory of Intellectual Property Offices
- Trade marks: News Service Archive
- Patents: Patent Examination Guidelines (German, French)
- Patents: Fees
Revisions to Patents Act as per 1 January 2019
A partial revision to the Patents Act and its implementing provisions will come into force together with an ordinary revision of the Therapeutic Products Act on 1 January 2019. This was decided by the Federal Council at its meeting on 21 September 2018 (Media release of 21 September 2018 in German/French/Italian).
The partial revision introduces the following improvements for medical personnel, pharmaceutical manufacturers and consumers:
Firstly, restrictions to the free choice of medical treatment will be removed, which is the result of a change in case law by the European Patent Office’s Enlarged Board of Appeal (see Question 11.1053 from former National Councillor Gysin). In addition, the prescription of medicines by medical personnel in individual cases and the individual preparation of medicines in pharmacies will be excluded from the effect of a patent.
Secondly, the revised Patents Act will encourage the development of safe medicinal products for paediatric use. As an incentive to remedy the lack of medicines specifically for children, the revised law will provide for a six-month extension to protection for pharmaceutical manufacturers as compensation for carrying out paediatric studies for medicinal products. This extended patent protection can be obtained with either a paediatric extension to a supplementary protection certificate or via the new paediatric protection certificate.
News
01.07.2022 | Trade Marks, ip-search, IPI
From July 2022, the IPI will no longer offer trade mark searches
...more
15.06.2022 | Trade Marks, Partners and initiatives
The IPI’s IP Management Award goes to Pettastic!
...more
24.05.2022 | Patents, Trade Marks
A strategy for success – how a Swiss start-up protects its inventions
...more
Events
14.04.2022 | Patents, Event, IPI
EPO/IPI - invitation to a free public online seminar on patenting topics in green tech
...more
01.10.2021 | Event, Partners and initiatives, IPI
How SMEs protect their primary raw material – know-how
...more